Sixth GCIG Ovarian Cancer Consensus Conference

GCIG-Intergroup-Horiz-rgb-300

October 15 – 21, 2021

Reply To: to do or not to do: interval debulking in NACT patients Nicoletta Colombo October 16, 2021

Forums › Topic Group 1 › to do or not to do: interval debulking in NACT patients › Reply To: to do or not to do: interval debulking in NACT patients

October 16, 2021 at 11:57 am #1110

Nicoletta Colombo

Participant

At least patients should not be progressing on NACT !!

GCIG-Intergroup-Horiz-rgb-300

6^th GCIG Ovarian Cancer Consensus Conference
on Clinical Research
October 15 – 21, 2021 – Online

Chair: Ignace Vergrote (BGOG)
Co-Chair: Michael Bookman (GOG-F)

Scientific Committee: Amit Oza (Chair GCIG), Keiichi Fujiwara (past-Chair, GCIG), Andres Poveda (past-Chair GCIG), Antonio Gonzalez-Martin (GEICO, Chair Ovarian Cancer Committee), Aikou Okamota (JGOG, past-Chair Ovarian Cancer Committee),Charlie Gourley (SGCTG, Chair Translational Research Committee), Jean-Emmanuel Kurtz (GINECO, Symptom Benefit Committee), Bénédicte Votan (GINECO, Chair Harmonization Operations), Alexander Reuss (AGO, Harmonization Statistics), Gavin Stuart (CCTG, Chair Finance Working Group), Iain McNeish (NCRI, ad hoc), Kathleen Moore (GOG-F, adhoc), Frederic Kridelka (BGOG, ad hoc), Mansoor Mirza (NSGO, ad hoc), Ketta Lorusso (MITO, ad hoc)

Administration/Organization Committee: Katherine Bennett (GCIG), Jennifer O’Donnell (GCIG), Sherill Osborne (GCIG)
BGOG office: Hanne Geleyns, Heidi Camps, Nancy Trolin

Copyright 2021

Terms of Service

Privacy Policy

X